| Southern Iowa Mental Health Center | |
|
1527 Albia Rd Ottumwa IA 52501-3907 | |
| (641) 682-8772 | |
| (641) 682-1924 |
| Full Name | Southern Iowa Mental Health Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 1527 Albia Rd, Ottumwa, Iowa |
| Authorized Official Name and Position | Christina Schark (EXECUTIVE DIRECTOR) |
| Authorized Official Contact | 6416828772 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Southern Iowa Mental Health Center 1527 Albia Rd Ottumwa IA 52501-3907 Ph: (641) 682-8772 | Southern Iowa Mental Health Center 1527 Albia Rd Ottumwa IA 52501-3907 Ph: (641) 682-8772 |
| NPI Number | 1659353670 |
|---|---|
| Provider Enumeration Date | 11/16/2005 |
| Last Update Date | 12/10/2021 |
| Certification Date | 09/10/2020 |
| Medicare PECOS PAC ID | 6002809647 |
|---|---|
| Medicare Enrollment ID | O20040407001335 |
News Archive
Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."
Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659353670 | NPI | - | NPPES |
| 1653953670 | Medicaid | IA | |
| 1659353670 | Other | BLUE CROSS & BLUE SHIELD OF IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
| Provider Name | Darissa D Chance |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1265425805 PECOS PAC ID: 8628981230 Enrollment ID: I20031110000630 |
News Archive
Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."
Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease.
› Verified 7 days ago
| Provider Name | Jimmy R Mascaro |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1104998251 PECOS PAC ID: 0042210973 Enrollment ID: I20061228000077 |
News Archive
Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."
Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease.
› Verified 7 days ago
| Provider Name | Hilda M Mascaro |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1427215110 PECOS PAC ID: 4284886003 Enrollment ID: I20130115000251 |
News Archive
Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."
Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease.
› Verified 7 days ago
| Provider Name | April K Davis |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1225339088 PECOS PAC ID: 8921234238 Enrollment ID: I20131114001764 |
News Archive
Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."
Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease.
› Verified 7 days ago
| Provider Name | Rhonda J Johnson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1154793446 PECOS PAC ID: 7517226350 Enrollment ID: I20180124000505 |
News Archive
Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."
Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease.
› Verified 7 days ago
| Provider Name | Shoshannah N Roberts |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1871944009 PECOS PAC ID: 1850643362 Enrollment ID: I20181011000909 |
News Archive
Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."
Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease.
› Verified 7 days ago
| Provider Name | Jennifer R Stromgren |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013525054 PECOS PAC ID: 0941614358 Enrollment ID: I20210126002660 |
News Archive
Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."
Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease.
› Verified 7 days ago
| Provider Name | Mendy M Shepard |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205588191 PECOS PAC ID: 5496148421 Enrollment ID: I20220215001170 |
News Archive
Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."
Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease.
› Verified 7 days ago
| Provider Name | Sydney A Thomas |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1326665373 PECOS PAC ID: 1254717549 Enrollment ID: I20221011001015 |
News Archive
Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."
Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease.
› Verified 7 days ago
| Provider Name | Kirby Rowl |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1679130967 PECOS PAC ID: 4880052513 Enrollment ID: I20230628000135 |
News Archive
Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."
Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease.
› Verified 7 days ago
| Provider Name | Rebecca A Cole |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1376942136 PECOS PAC ID: 7315246659 Enrollment ID: I20231026002818 |
News Archive
Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."
Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease.
› Verified 7 days ago
| Provider Name | Allison D Brown |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1700353083 PECOS PAC ID: 3577911379 Enrollment ID: I20231204002119 |
News Archive
Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."
Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease.
› Verified 7 days ago
News Archive
Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."
Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease.
› Verified 7 days ago
Psychology Services Of Ottumwa Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 226 W Main St Ste 208, Ottumwa, IA 52501 Phone: 479-530-7003 | |
Alexander Enterprises Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1207 N Jefferson St, Ottumwa, IA 52501 Phone: 641-682-5437 | |
Lrc Vision Of Hope Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 619 Church St # 2013, Ottumwa, IA 52501 Phone: 704-615-9344 | |
Sieda Substance Abuse Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 310 W. Main St, Ottumwa, IA 52501 Phone: 641-683-6747 Fax: 641-683-6317 | |
First Resources Corp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 102 N Hancock St, Ottumwa, IA 52501 Phone: 641-683-1302 Fax: 641-683-1309 | |
Ottumwa Psychiatric Clinic Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1112 N Van Buren Ave, Suite 2, Ottumwa, IA 52501 Phone: 641-684-7744 Fax: 641-684-7700 | |
Senior Behavioral Care Center Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1001 Pennsylvania Ave, Attn: Facility Ceo, Ottumwa, IA 52501 Phone: 641-684-2300 Fax: 641-684-2324 |